Global Antiphospholipid Syndrome Score (GAPSS) in patients with primary antiphospholipid syndrome
Stratification of patients into groups of high and low risk of adverse outcome is necessary for timely and early prevention of the disease, as well as the selection of adequate therapy.Objective: to validate the global risk scale for the development of clinical manifestations of antiphospholipid syn...
Main Authors: | F. A. Cheldieva, T. M. Reshetnyak, A. A. Shumilova, K. S. Nurbaeva, M. V. Cherkasova, E. Yu. Samarkina, A. M. Lila |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2023-02-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1385 |
Similar Items
-
Assessment of the activity and organ damage in antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2021-08-01) -
Clinical significance of antibodies to the phosphatidylserine/prothrombin complex
by: T. M. Reshetnyak, et al.
Published: (2022-05-01) -
Thromboembolic complications in antiphospholipid syndrome and ankylosing spondylitis (two clinical cases)
by: K. S. Nurbaeva, et al.
Published: (2021-02-01) -
Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)
by: F. A. Cheldieva, et al.
Published: (2021-10-01) -
Catastrophic antiphospholipid COVID-19 syndrome
by: Yu. S. Polushin, et al.
Published: (2021-03-01)